484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors

Stephane Champiat, Aurélien Marabelle, Aung Naing, Filip Janku, Patricia LoRusso, David Béchard, Elena Garralda, Vladimir Galvao, Peter Grell, Richard Sachse, Joachim Kiemle-Kallee

Open source

DOI: 10.1136/jitc-2021-sitc2021.484
Published: November
Container: Journal for ImmunoTherapy of Cancer
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2021-sitc2021.484,
  title = {484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors},
  author = {Stephane Champiat and Aurélien Marabelle and Aung Naing and Filip Janku and Patricia LoRusso and David Béchard and Elena Garralda and Vladimir Galvao and Peter Grell and Richard Sachse and Joachim Kiemle-Kallee},
  year = {2021},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2021-sitc2021.484},
  url = {https://doi.org/10.1136/jitc-2021-sitc2021.484}
}

RIS

TY  - JOUR
TI  - 484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors
AU  - Stephane Champiat
AU  - Aurélien Marabelle
AU  - Aung Naing
AU  - Filip Janku
AU  - Patricia LoRusso
AU  - David Béchard
AU  - Elena Garralda
AU  - Vladimir Galvao
AU  - Peter Grell
AU  - Richard Sachse
AU  - Joachim Kiemle-Kallee
PY  - 2021
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2021-sitc2021.484
UR  - https://doi.org/10.1136/jitc-2021-sitc2021.484
ER  -

APA

Champiat, S., Marabelle, A., Naing, A., Janku, F., LoRusso, P., Béchard, D., Garralda, E., Galvao, V., Grell, P., Sachse, R., & Kiemle-Kallee, J. (2021). 484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2021-sitc2021.484

Source records

doaj · retrieved 2026-09-26T15:17:08.641Z